The Europe eClinical solutions Market would witness market growth of 13.1% CAGR during the forecast period (2022-2028).
The main factor influencing the use of eClinical solutions, particularly in industrialized nations like the United States, is the existence of stringent requirements for clinical trials along with the growing demand for safety monitoring. In addition, governments of several nations are taking initiatives to increase the number of users of eClinical solutions.
In patient-centric clinical trials, sponsors may decide to use virtual & remote technologies to support their findings, although these approaches usually do little to encourage patient participation or retention. Prior to the pandemic, retaining and ensuring patient participation in clinical trials was an issue. Undeveloped, cumbersome virtual tools that support patient participation, regardless of a trial's design or level of reliance on eClinical technologies, can lead to cost and time overruns through attrition.
One of the main ways clinical trial teams may enhance patient adherence and retention, improve trial outcomes, and pave the way for novel and promising therapeutics is by optimizing these tools to promote patient participation. There are various types of eClinical solutions available in the market such as the electric data capture system market.
New healthcare solutions are required in the region due to the growing financial strain on NHS healthcare spending. The U.K. healthcare industry is anticipated to develop as a result of an aging population and an increase in the prevalence of chronic diseases that can be treated at home, such as incontinence, ostomy, diabetic foot ulcer, etc. Additionally, technical developments in healthcare equipment have improved the level of care provided to the dependent aged population and patients receiving treatment for chronic conditions.
The Germany market dominated the Europe eClinical Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,335.7 Million by 2028. The UK market is experiencing a CAGR of 12.2% during (2022 - 2028). Additionally, The France market is exhibiting a CAGR of 14% during (2022 - 2028).
Based on Delivery Mode, the market is segmented into Web-based (on-demand) Model, Licensed enterprise (On-premise) Model and Cloud-based (SaaS) Model. Based on Product, the market is segmented into CDMS/EDC Solutions, CTMS Solutions, Analytics & Reporting Platforms, Safety Solutions, Integration Platforms, RTMS Solutions, eCOA Solutions and Others. Based on Clinical Trials Phase, the market is segmented into Phase III, Phase II, Phase IV and Phase I. Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions, Hospitals, Contract Research Organizations, Medical Device Manufacturers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global eClinical solutions Market will Hit $20.1 Billion by 2028, at a CAGR of 13.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, Anju Software, Inc., eClinical Solutions LLC, Castor EDC, Signant Health, Dassault Systemes SE, Parexel International Corporation (Phoenix Parentco, Inc.), Clario, BSI Life Sciences (Business Systems Integration AG) and MedNet Solutions
By Delivery Mode
By Product
By Clinical Trials Phase
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 